Nanoparticles Engineered with Rituximab and Loaded with Nutlin-3 Show Promising Therapeutic Activity in B-Leukemic XenograftsRebecca Voltan, Giorgio Zauli, Flavio Forni et al.|Clinical Cancer Research|2013Cited by 33
Nanoparticles Loaded with Nutlin-3 Display Cytotoxicity Towards p53<sup>wildtype</sup> JVM-2 But Not Towards p53<sup>mutated</sup> BJAB Leukemic CellsRebecca Voltan, Maria Angela Vandelli, Paola Secchiero et al.|Current Medicinal Chemistry|2013Cited by 13